The role of integration in oncogenic progression of HPV-associated cancers

PLoS Pathogens

Volumn 13, Issue 4, 2017, Pages

  McBride, Alison A ^a   Warburton, Alix ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; INTEGRATION HOST FACTOR; PROTEIN E6; PROTEIN E7;

CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DNA TRANSCRIPTION; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; NONHUMAN; REVIEW; TRANSCRIPTION REGULATION; TUMOR VIRUS; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS ONCOGENE; WART VIRUS; GENETICS; NEOPLASM; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PHYSIOLOGY; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

HUMANS; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIRUS INTEGRATION;

EID: 85018330085     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006211     Document Type: Review

References (39)

1. Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I, Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25Suppl 1(S1):2–23.
2. Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, et al. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014;111(43):15544–9. Epub 2014/10/15. doi: 10.1073/pnas.1416074111 25313082
3. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985;314(6006):111–4. 2983228
4. Wentzensen N, Vinokurova S, von Knebel Doeberitz M, Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004;64(11):3878–84. Epub 2004/06/03. doi: 10.1158/0008-5472.CAN-04-0009 15172997
5. Shukla S, Mahata S, Shishodia G, Pande S, Verma G, Hedau S, et al. Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. The Indian journal of medical research. 2014;139(4):531–43. Epub 2014/06/14. 24927339
6. Jeon S, Allen-Hoffmann BL, Lambert PF, Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol. 1995;69(5):2989–97. Epub 1995/05/01. 7707525
7. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D, Hwang ES, Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci U S A. 2000;97(20):10978–83. Epub 2000/09/27. 11005870
8. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz M, Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene. 2002;21(3):419–26. doi: 10.1038/sj.onc.1205104 11821954
9. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, et al. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. JVirol. 2004;78(20):11172–86.
10. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M, Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009;5(4):e1000397. Epub 2009/04/25. doi: 10.1371/journal.ppat.1000397 19390600
11. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M, Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J. 2007;26(8):2180–91. doi: 10.1038/sj.emboj.7601665 17396148
12. Chaiwongkot A, Vinokurova S, Pientong C, Ekalaksananan T, Kongyingyoes B, Kleebkaow P, et al. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer. 2013;132(9):2087–94. doi: 10.1002/ijc.27906 23065631
13. Thierry F, Yaniv M, The Bpv1-E2 Trans-Acting Protein Can Be Either an Activator or a Repressor of the Hpv18 Regulatory Region. Embo Journal. 1987;6(11):3391–7. 2828029
14. Leung TW, Liu SS, Leung RC, Chu MM, Cheung AN, Ngan HY, HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis. J Med Virol. 2015;87(6):1022–33. Epub 2015/02/05. doi: 10.1002/jmv.24129 25648229
15. Dooley KE, Warburton A, McBride AA, Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes. mBio. 2016;7(5).
16. Sakakibara N, Mitra R, McBride AA, The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol. 2011;85(17):8981–95. doi: 10.1128/JVI.00541-11 21734054
17. Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, Archambault J, Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol. 2011;85(17):8996–9012. doi: 10.1128/JVI.00542-11 21734051
18. Jeon S, Lambert PF, Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. ProcNatlAcadSciUSA. 1995;92:1654–8.
19. Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N, Genomic characterization of viral integration sites in HPV-related cancers. Int J Cancer. 2016;139(9):2001–11. Epub 2016/06/28. doi: 10.1002/ijc.30243 27343048
20. Kristiansen E, Jenkins A, Holm R, Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol. 1994;47(3):253–6. Epub 1994/03/01. 7677803
21. Dong XP, Stubenrauch F, Beyer-Finkler E, Pfister H, Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. IntJCancer. 1994;58(6):803–8.
22. Bhattacharjee B, Sengupta S, CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology. 2006;354(2):280–5. doi: 10.1016/j.virol.2006.06.018 16905170
23. Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF, Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. JVirol. 2003;77(23):12450–9.
24. Reuschenbach M, Huebbers CU, Prigge ES, Bermejo JL, Kalteis MS, Preuss SF, et al. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers. Cancer. 2015;121(12):1966–76. Epub 2015/03/04. doi: 10.1002/cncr.29315 25731880
25. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017. Epub 2017/01/24.
26. Cullen AP, Reid R, Campion M, Lorincz AT, Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991;65(2):606–12. Epub 1991/02/01. 1846186
27. Vojtechova Z, Sabol I, Salakova M, Turek L, Grega M, Smahelova J, et al. Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis. Int J Cancer. 2016;138(2):386–95. doi: 10.1002/ijc.29712 26239888
28. Gao G, Johnson SH, Vasmatzis G, Pauley CE, Tombers NM, Kasperbauer JL, et al. Common Fragile Sites and Extremely Large are Targets for Human Papillomavirus Integrations and Chromosome Rearrangements in Oropharyngeal Squamous Cell Carcinoma. Genes Chromosomes Cancer. 2016. Epub 2016/09/17.
29. Olthof NC, Speel EJ, Kolligs J, Haesevoets A, Henfling M, Ramaekers FC, et al. Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS ONE. 2014;9(2):e88718. doi: 10.1371/journal.pone.0088718 24586376
30. Valmary-Degano S, Jacquin E, Pretet JL, Monnien F, Girardo B, Arbez-Gindre F, et al. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Human pathology. 2013;44(6):992–1002. Epub 2012/12/26. doi: 10.1016/j.humpath.2012.08.019 23266444
31. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 2000;60(21):5916–21. Epub 2000/11/21. 11085503
32. Christiansen IK, Sandve GK, Schmitz M, Durst M, Hovig E, Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis. PLoS ONE. 2015;10(3):e0119566. Epub 2015/03/21. doi: 10.1371/journal.pone.0119566 25793388
33. Durst M, Croce CM, Gissmann L, Schwarz E, Huebner K, Papillomavirus Sequences Integrate near Cellular Oncogenes in Some Cervical Carcinomas. Proceedings of the National Academy of Sciences of the United States of America. 1987;84(4):1070–4. 3029760
34. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene. 2003;22(46):7233–42. doi: 10.1038/sj.onc.1207006 14562053
35. Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, et al. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2014;24(2):185–99. doi: 10.1101/gr.164806.113 24201445
36. Xu B, Chotewutmontri S, Wolf S, Klos U, Schmitz M, Durst M, et al. Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas. PLoS ONE. 2013;8(6):e66693. doi: 10.1371/journal.pone.0066693 23824673
37. Peter M, Stransky N, Couturier J, Hupe P, Barillot E, de Cremoux P, et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol. 2010;221(3):320–30. Epub 2010/06/09. doi: 10.1002/path.2713 20527025
38. Jang MK, Shen K, McBride AA, Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome. PLoS Pathog. 2014;10(5):e1004117. doi: 10.1371/journal.ppat.1004117 24832099
39. Groves IJ, Knight EL, Ang QY, Scarpini CG, Coleman N, HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome. Oncogene. 2016.